Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients

Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients

Abstract Aim Soluble suppression of tumorigenicity‐2 (sST2) is a strong prognostic biomarker in heart failure. The emerging understanding of circadian biology in cardiovascular disease may lead to novel applications in prognosis and diagnosis and may provide insight into mechanistic aspects of the d...

Full description

Bibliographic Details
Main Authors: Sandra Crnko, Markella I. Printezi, Tijn P.J. Jansen, Laurynas Leiteris, Manon G. van derMeer, Hilde Schutte, Martijn vanFaassen, Bastiaan C. duPré, Nicolaas deJonge, Folkert W. Asselbergs, Carlo A.J.M. Gaillard, Hans Kemperman, Pieter A. Doevendans, Joost P.G. Sluijter, Linda W. vanLaake
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:ESC Heart Failure
Subjects:
Circadian rhythm
Diurnal rhythm
Heart failure
Biomarker
sST2
NT‐proBNP
Online Access:https://doi.org/10.1002/ehf2.12673

Internet

https://doi.org/10.1002/ehf2.12673

Similar Items